Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 03, 2026
Schlumberger (SLB) Stock Rises +15% in 30 Days: Earnings Beat and ChampionX Integration in Focus

Schlumberger (SLB) Stock Rises +15% in 30 Days: Earnings Beat and ChampionX Integration in Focus

Key Takeaways

  • SLB stock rose approximately +15% over the past 30 days, driven primarily by better-than-expected Q1 2026 earnings and positive integration from the ChampionX acquisition.
  • Over the past quarter, shares gained around +14%, reflecting recovery from mid-March lows amid Middle East disruptions, bolstered by sector resilience and revenue growth.
  • Key catalysts include Q1 revenue of $8.72 billion (up 3% year-over-year) and adjusted EBITDA contributions from ChampionX, despite geopolitical headwinds.
  • Oilfield services demand and digital technology advancements supported upward momentum, with analysts maintaining a generally positive outlook.
  • Broader energy market trends and upstream spending stabilization influenced quarterly performance positively.

Schlumberger (SLB): Business Overview and Market Position

Schlumberger Limited (SLB), the world's leading provider of technology and services to the energy industry, specializes in reservoir characterization, drilling, production, and processing. The company operates a technology-driven business model, offering integrated solutions from digital platforms to offshore equipment, serving oil and gas exploration and production worldwide. As a dominant player in the oilfield services sector—holding about 30% market share in high-end drilling and reservoir services—SLB benefits from exposure to global energy demand and technological innovation. Its shift toward digital and production systems has enhanced margins, explaining resilience amid volatile commodity prices and supporting recent stock price gains through diversified revenue streams. From what I see, this positioning gives SLB a clear edge in the sector.

SLB Stock Performance: 30 Days vs. Past Quarter

Over the last 30 days, SLB stock advanced roughly +15%, moving from around $50 to $57 in a steady upward trend punctuated by volatility around earnings. The price climbed steadily post-Q1 report, reflecting investor confidence. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

For the past quarter, shares posted a +14% gain, recovering from a mid-March dip to the mid-$40s before rallying into late April and early May. Movement was trend-driven with notable swings tied to news events, but overall range-bound early in the period before breaking higher.

Key Drivers Behind SLB's 30-Day Gain

The primary catalyst was SLB's Q1 2026 earnings release on April 24, which showed revenue of $8.72 billion, up 3% year-over-year, and EPS of $0.50, beating analyst estimates by 1.31% on earnings and 1.09% on revenue. Shares jumped over 4% that day amid optimism over ChampionX integration, adding $838 million in revenue and $199 million in adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization). Despite Middle East disruptions impacting operations, management highlighted accretive growth in production systems (up 23% year-over-year). Positive market sentiment toward energy security and digital initiatives further propelled the stock higher, with bullish options activity noted. One thing that stands out to me is how these results underscore SLB's operational strength.

Factors Driving SLB Performance Over the Quarter

The quarter's +14% rise stemmed from broader recovery in oilfield services amid stabilizing energy demand, offsetting early pressures. A negative preannouncement in early March cited Middle East conflicts, causing a drop to $44 lows, but shares rebounded on resilient fundamentals. ChampionX's pro forma growth and synergy capture provided sustained lift, while global upstream spending held firmer than feared. Sector trends, including a projected 4.5% CAGR for oilfield services through 2036, supported positioning. Institutional interest and analyst buy ratings countered a January downgrade, with cumulative impact from earnings beats driving the net uptrend. In my view, this resilience highlights why I'm watching SLB closely.

Trending AI Robots

One tool I rely on for exploring automated trading strategies is Tickeron’s Trending AI Robots page, which showcases the top-performing AI trading bots from its extensive library of hundreds of algorithms actively trading thousands of tickers across various markets. These curated bots are selected based on recent performance metrics, relevance to current market conditions, and strategy diversity—including momentum, mean reversion, and machine learning models—spanning short-term scalping to long-term trend following. I appreciate being able to review detailed backtests, live results, win rates, and risk-adjusted returns to find bots that match my approach. It's a practical way to discover automated strategies that could enhance portfolio management.

What to Watch for SLB Stock Moving Forward

Investors should monitor upcoming Q2 earnings in July for updates on ChampionX synergies and international revenue growth. Geopolitical tensions in the Middle East remain a risk, alongside oil price fluctuations impacting upstream spending. Progress in digital oilfield technologies and new contracts in offshore and production systems could act as catalysts. Broader energy transition trends, interest rate environment, and competitor dynamics in oilfield services will influence sentiment. Regulatory shifts and macroeconomic demand signals for energy security are also key factors to track. This is important because these elements could shape SLB's trajectory in the coming months.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: SLB

Contributor

Alicia's AvatarAlicia|Beginner

SLB sees MACD Histogram just turned negative

SLB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 27 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SLB as a result. In 55 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

SLB moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SLB crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for SLB entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLB's RSI Indicator exited the oversold zone, 18 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLB advanced for three days, in 217 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

SLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.931) is normal, around the industry mean (3.496). P/E Ratio (25.117) is within average values for comparable stocks, (88.534). Projected Growth (PEG Ratio) (1.357) is also within normal values, averaging (1.687). Dividend Yield (0.023) settles around the average of (0.012) among similar stocks. P/S Ratio (2.166) is also within normal values, averaging (1.663).

The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SLB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are SLB Limited (NYSE:SLB), Halliburton Company (NYSE:HAL).

Industry description

The oilfield services/equipment industry is involved in providing various equipment and services to oil and natural gas producers. These companies rent drilling rigs and/or provide services to build and maintain oil and gas wells. The performance of this industry is dependent on demand for oil and natural gas, which in turn is often driven by macroeconomic conditions or business cycles. Schlumberger NV, Halliburton Company, and Baker Hughes are some of the biggest oilfield services companies.

Market Cap

The average market capitalization across the Oilfield Services/Equipment Industry is 6.13B. The market cap for tickers in the group ranges from 43.89 to 76.42B. SLB holds the highest valuation in this group at 76.42B. The lowest valued company is KEGX at 43.89.

High and low price notable news

The average weekly price growth across all stocks in the Oilfield Services/Equipment Industry was 6%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -5%. GOW experienced the highest price growth at 118%, while NESR experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Oilfield Services/Equipment Industry was -6%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 31
Price Growth Rating: 56
SMR Rating: 74
Profit Risk Rating: 65
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
SLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of oilfield services such as distributing oil and gas information technologies and providing consulting services

Industry OilfieldServicesEquipment

Industry
Oilfield Services Or Equipment
Address
5599 San Felipe
Phone
+1 713 513-2000
Employees
109000
Web
https://www.slb.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.